Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, OH, USA.
Dig Dis Sci. 2012 Feb;57(2):528-34. doi: 10.1007/s10620-011-2006-2. Epub 2011 Dec 20.
A possible association between nonalcoholic fatty liver disease (NAFLD) and hypothyroidism has been suggested. The recognized link between hypothyroidism and elements of the metabolic syndrome may explain this association.
The purpose of this study was to determine the prevalence of hypothyroidism in a cohort of patients with NAFLD and analyze the potential factors associated with hypothyroidism in this patient population.
Two hundred forty-six patients with biopsy-proven NAFLD attending hepatology clinics at the Cleveland Clinic between October 2006 and June 2009, and 430 age-, gender-, race- and BMI-matched control subjects seen in the general internal medicine clinic were included. Patients with a clinical diagnosis of hypothyroidism who were on thyroid replacement therapy were considered to be hypothyroid.
Hypothyroidism was more frequent among patients with NAFLD (21% vs. 9.5%; P < 0.01) compared to controls, and was higher in NASH patients than NAFLD patients without NASH (25% vs. 12.8%, P = 0.03). Subjects with hypothyroidism were 2.1 (95% CI 1.1-3.9, P = 0.02) and 3.8 (95% CI 2-6.9, P < 0.001) times more likely to have NAFLD and NASH, respectively. By multivariate analysis, female gender (P < 0.001) and increased BMI (P = 0.03) were associated with hypothyroidism. NAFLD subjects who reported mild alcohol consumption were less likely to have hypothyroidism compared to those who reported complete abstinence (OR 0.37, P = 0.008).
A higher prevalence of hypothyroidism was demonstrated in patients with NAFLD compared to controls. Among subjects with NALFD, female gender, increased BMI and history of abstinence from alcohol were associated with hypothyroidism. Patients with hypothyroidism were also more likely to have NASH.
非酒精性脂肪性肝病(NAFLD)与甲状腺功能减退之间可能存在关联。甲状腺功能减退与代谢综合征的某些元素之间的已知联系可能解释了这种关联。
本研究旨在确定在一组经活检证实为 NAFLD 的患者中甲状腺功能减退的患病率,并分析该患者人群中与甲状腺功能减退相关的潜在因素。
纳入 2006 年 10 月至 2009 年 6 月期间在克利夫兰诊所肝脏病学诊所就诊的 246 例经活检证实为 NAFLD 的患者和在普通内科诊所就诊的 430 例年龄、性别、种族和 BMI 匹配的对照组患者。患有临床诊断为甲状腺功能减退症并正在接受甲状腺替代治疗的患者被认为患有甲状腺功能减退症。
与对照组相比,NAFLD 患者的甲状腺功能减退症更为常见(21%比 9.5%;P<0.01),并且 NASH 患者的甲状腺功能减退症发生率高于无 NASH 的 NAFLD 患者(25%比 12.8%,P=0.03)。患有甲状腺功能减退症的患者患 NAFLD 和 NASH 的可能性分别为 2.1 倍(95%CI 1.1-3.9,P=0.02)和 3.8 倍(95%CI 2-6.9,P<0.001)。多变量分析显示,女性(P<0.001)和 BMI 增加(P=0.03)与甲状腺功能减退症相关。与报告完全戒酒的患者相比,报告轻度饮酒的 NAFLD 患者发生甲状腺功能减退症的可能性较低(OR 0.37,P=0.008)。
与对照组相比,NAFLD 患者的甲状腺功能减退症患病率更高。在患有 NALFD 的患者中,女性、BMI 增加和酒精戒断史与甲状腺功能减退症相关。患有甲状腺功能减退症的患者也更有可能患有 NASH。